MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Isolated ATP synthase deficiency
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Malignant neoplasm of urinary bladder
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Bladder Neoplasm
|
0.300 |
Biomarker
|
disease |
CTD_human |
Identification of novel gene targets and putative regulators of arsenic-associated DNA methylation in human urothelial cells and bladder cancer.
|
26039340 |
2015 |
Myocardial Infarction
|
0.200 |
Biomarker
|
disease |
RGD |
iTRAQ-Based Proteomic Analysis Reveals Recovery of Impaired Mitochondrial Function in Ischemic Myocardium by Shenmai Formula.
|
29300489 |
2018 |
Obesity
|
0.200 |
Therapeutic
|
disease |
RGD |
A combination of resveratrol and quercetin induces browning in white adipose tissue of rats fed an obesogenic diet.
|
27874268 |
2017 |
Cardiomegaly
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Astragalus polysaccharide attenuates isoproterenol-induced cardiac hypertrophy by regulating TNF-α/PGC-1α signaling mediated energy biosynthesis.
|
25880160 |
2015 |
Myocardial Reperfusion Injury
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions.
|
26109848 |
2015 |
Left Ventricular Hypertrophy
|
0.200 |
Therapeutic
|
disease |
RGD |
Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
|
25738576 |
2015 |
Calcification of the aorta
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Calpain-1 Mediated Disorder of Pyrophosphate Metabolism Contributes to Vascular Calcification Induced by oxLDL.
|
26047104 |
2015 |
Myocardial Reperfusion Injury
|
0.200 |
Biomarker
|
phenotype |
RGD |
ROCK-dependent ATP5D modulation contributes to the protection of notoginsenoside NR1 against ischemia-reperfusion-induced myocardial injury.
|
25305180 |
2014 |
Colitis
|
0.200 |
Therapeutic
|
disease |
RGD |
Huang Qi Jian Zhong Pellet Attenuates TNBS-Induced Colitis in Rats via Mechanisms Involving Improvement of Energy Metabolism.
|
23840258 |
2013 |
Myocardial Infarction
|
0.200 |
Therapeutic
|
disease |
RGD |
Astragaloside IV protects heart from ischemia and reperfusion injury via energy regulation mechanisms.
|
23809007 |
2013 |
Hyperammonemia
|
0.110 |
GeneticVariation
|
phenotype |
BEFREE |
Here, we describe two individuals, each with homozygous missense variants in ATP5F1D, who presented with episodic lethargy, metabolic acidosis, 3-methylglutaconic aciduria, and hyperammonemia.
|
29478781 |
2018 |
Mitochondrial Diseases
|
0.110 |
GeneticVariation
|
group |
BEFREE |
Our data establish c.245C>T (p.Pro82Leu) and c.317T>G (p.Val106Gly) in ATP5F1D as pathogenic variants leading to a Mendelian mitochondrial disease featuring episodic metabolic decompensation.
|
29478781 |
2018 |
Mitochondrial Diseases
|
0.110 |
CausalMutation
|
group |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Hyperammonemia
|
0.110 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cardiomyopathy, Dilated
|
0.100 |
CausalMutation
|
group |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Patent ductus arteriosus
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Heart murmur
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Hypoglycemia
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Left-Sided Heart Failure
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |
Lethargy
|
0.100 |
CausalMutation
|
phenotype |
CLINVAR |
Biallelic Mutations in ATP5F1D, which Encodes a Subunit of ATP Synthase, Cause a Metabolic Disorder.
|
29478781 |
2018 |